Skip to main content

and
  1. Article

    Open Access

    Immunologically “cold” triple negative breast cancers engraft at a higher rate in patient derived xenografts

    TNBC is a heterogeneous subtype of breast cancer, and only a subset of TNBC can be established as PDXs. Here, we show that there is an engraftment bias toward TNBC with low levels of immune cell infiltration. ...

    Varduhi Petrosyan, Lacey E. Dobrolecki, Emily L. LaPlante in npj Breast Cancer (2022)

  2. Article

    Author Correction: PHGDH heterogeneity potentiates cancer cell dissemination and metastasis

    Matteo Rossi, Patricia Altea-Manzano, Margherita Demicco, Ginevra Doglioni in Nature (2022)

  3. Article

    Open Access

    Correction to: In Vivo Modeling of Human Breast Cancer Using Cell Line and Patient-Derived Xenografts

    Eric P. Souto, Lacey E. Dobrolecki in Journal of Mammary Gland Biology and Neopl… (2022)

  4. Article

    Open Access

    In Vivo Modeling of Human Breast Cancer Using Cell Line and Patient-Derived Xenografts

    Historically, human breast cancer has been modeled largely in vitro using long-established cell lines primarily in two-dimensional culture, but also in three-dimensional cultures of varying cellular and molecu...

    Eric P. Souto, Lacey E. Dobrolecki in Journal of Mammary Gland Biology and Neopl… (2022)

  5. No Access

    Article

    PHGDH heterogeneity potentiates cancer cell dissemination and metastasis

    Cancer metastasis requires the transient activation of cellular programs enabling dissemination and seeding in distant organs1. Genetic, transcriptional and translational heterogeneity contributes to this dynamic...

    Matteo Rossi, Patricia Altea-Manzano, Margherita Demicco, Ginevra Doglioni in Nature (2022)

  6. Article

    Open Access

    A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology

    Models that recapitulate the complexity of human tumors are urgently needed to develop more effective cancer therapies. We report a bank of human patient-derived xenografts (PDXs) and matched organoid cultures...

    Katrin P. Guillen, Maihi Fujita, Andrew J. Butterfield, Sandra D. Scherer in Nature Cancer (2022)

  7. No Access

    Protocol

    Surgical Procedure for Implantation of Human Tumor Tissue into the Epithelium-Free Mammary Fat Pad of Immunocompromised Mice to Generate Patient-Derived Xenografts (PDX)

    Implantation of cancerous tissue obtained from patient biopsies or surgical procedures to create patient-derived xenograft models (PDX) has greatly enhanced the ability of scientists and physicians to perform ...

    Lacey E. Dobrolecki, Michael T. Lewis in Mammary Stem Cells (2022)

  8. No Access

    Article

    C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes

    To improve cancer patient outcome significantly, we must understand the mechanisms regulating stem-like cancer cells, which have been implicated as a cause of metastasis and treatment resistance. The transcrip...

    Kuppusamy Balamurugan, Daniel Mendoza-Villanueva, Shikha Sharan in Oncogene (2019)

  9. Article

    Open Access

    Circulating tumor cell investigation in breast cancer patient-derived xenograft models by automated immunofluorescence staining, image acquisition, and single cell retrieval and analysis

    Breast cancer patient-derived xenograft (BC-PDX) models represent a continuous and reproducible source of circulating tumor cells (CTCs) for studying their role in tumor biology and metastasis. We have previou...

    Arturo B. Ramirez, Raksha Bhat, Debashish Sahay, Carmine De Angelis in BMC Cancer (2019)

  10. Article

    Open Access

    Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer

    Intratumoral heterogeneity in cancers arises from genomic instability and epigenomic plasticity and is associated with resistance to cytotoxic and targeted therapies. We show here that cell-state heterogeneity...

    Tyler Risom, Ellen M. Langer, Margaret P. Chapman, Juha Rantala in Nature Communications (2018)

  11. No Access

    Article

    Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer

    Targeting tyrosine kinase receptors that share the feedback inhibitor PTPN12 leads to broad spectrum therapeutic suppression of triple-negative breast cancer.

    Amritha Nair, Hsiang-Ching Chung, Tingting Sun, Siddhartha Tyagi in Nature Medicine (2018)

  12. No Access

    Article

    Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming

    The cross-talk between immune cells and blood vessel endothelial cells promotes pericyte coverage and decreases hypoxia in mouse tumour models, and correlative evidence suggests that these processes influence ...

    Lin Tian, Amit Goldstein, Hai Wang, Hin Ching Lo, Ik Sun Kim, Thomas Welte in Nature (2017)

  13. No Access

    Article

    Patient-derived xenograft (PDX) models in basic and translational breast cancer research

    Patient-derived xenograft (PDX) models of a growing spectrum of cancers are rapidly supplanting long-established traditional cell lines as preferred models for conducting basic and translational preclinical re...

    Lacey E. Dobrolecki, Susie D. Airhart, Denis G. Alferez in Cancer and Metastasis Reviews (2016)

  14. Article

    Erratum: Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation

    Nature Cell Biology 18, 632–644 (2016); published online 16 May 2016; corrected after print 20 May 2016 In the version of this Article originally published, in the fourth affiliation, 'Los Angeles' should have...

    Thomas Welte, Ik Sun Kim, Lin Tian, **a Gao, Hai Wang, June Li in Nature Cell Biology (2016)

  15. No Access

    Article

    Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation

    Myeloid-derived suppressor cells (MDSCs) play critical roles in primary and metastatic cancer progression. MDSC regulation is widely variable even among patients harbouring the same type of malignancy, and the...

    Thomas Welte, Ik Sun Kim, Lin Tian, **a Gao, Hai Wang, June Li in Nature Cell Biology (2016)

  16. Article

    Open Access

    Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis

    Real-time monitoring of biologic changes in tumors may be possible by investigating the transitional cells such as circulating tumor cells (CTCs) and disseminated tumor cells in bone marrow (BM-DTCs). However,...

    Mario Giuliano, Sabrina Herrera, Pavel Christiny, Chad Shaw in Breast Cancer Research (2015)